Lenders weighing Organon financing options in Sun Pharma bid
Lenders weighing Organon financing options signal Sun Pharma’s potential bridge loan or short-term facility as part of a broader $12 billion deal strategy.
India outbound deal: Organon acquisition by Sun Pharma? —
India outbound deal Organon acquisition: Sun Pharma reportedly pursues a bid around $12–13 billion for Organon, with terms and final status not yet confirmed.